Long-Term Outcome of Amyotrophic Lateral Sclerosis in Korean Subjects
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to analyze the predictors of prognosis.Methods Subjects who were diagnosed with ALS between January 2005 and December 2009 at a single institute were followed up until death or up to December 2014. Data regarding age, sex, date of onset, date of diagnosis, presence of bulbar symptoms on onset, date of initiation of non-invasive ventilation (NIV), and the date of tracheostomy were collected. Survival was assessed using Kaplan-Meier curves and multivariate analyses of the risk of death were performed using the Cox proportional hazards model. Results Among 212 suspicious subjects, definite ALS was diagnosed in 182 subjects. The survival rate at 3 and 5 years from onset was 61.5% and 40.1%, respectively, and the survival rate at 3 and 5 years post-diagnosis was 49.5% and 24.2%, respectively. Further, 134 patients (134/182, 73.6%) were initiated on NIV, and among them, 90 patients (90/182, 49.5%) underwent tracheostomy. Male gender and onset age of ≥65 years were independent predictors of adverse survival.Conclusion The analysis of long term survival in ALS showed excellent outcomes considering the overall poor prognosis of this disease.
Abstract
Objective To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to analyze the predictors of prognosis.Methods Subjects who were diagnosed with ALS between January 2005 and December 2009 at a single institute were followed up until death or up to December 2014. Data regarding age, sex, date of onset, date of diagnosis, presence of bulbar symptoms on onset, date of initiation of non-invasive ventilation (NIV), and the date of tracheostomy were collected. Survival was assessed using Kaplan-Meier curves and multivariate analyses of the risk of death were performed using the Cox proportional hazards model. Results Among 212 suspicious subjects, definite ALS was diagnosed in 182 subjects. The survival rate at 3 and 5 years from onset was 61.5% and 40.1%, respectively, and the survival rate at 3 and 5 years post-diagnosis was 49.5% and 24.2%, respectively. Further, 134 patients (134/182, 73.6%) were initiated on NIV, and among them, 90 patients (90/182, 49.5%) underwent tracheostomy. Male gender and onset age of ≥65 years were independent predictors of adverse survival.Conclusion The analysis of long term survival in ALS showed excellent outcomes considering the overall poor prognosis of this disease.
참고문헌 (19)
- Chancellor AM, "The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register", J Neurol, 240, pp.339~346 (1993)
- Norris F, "Onset, natural history and outcome in idiopathic adult motor neuron disease", J Neurol Sci, 118, pp.48~55 (1993)
- Ringel SP, "The natural history of amyotrophic lateral sclerosis", Neurology, 43, pp.1316~1322 (1993)
- Chancellor AM, "Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950", J Neurol Neurosurg Psychiatry, 55, pp.1106~1115 (1992)
- Strand EA, "Management of oral-pharyngeal dysphagia symptoms in amyotrophic lateral sclerosis", Dysphagia, 11, pp.129~139 (1996)
- Qureshi M, "The natural history of ALS is changing: improved survival", Amyotroph Lateral Scler, 10, pp.324~331 (2009)
- Pupillo E, "Long-term survival in amyotrophic lateral sclerosis: a population-based study", Ann Neurol, 75, pp.287~297 (2014)
- Dreyer P, "Survival in ALS with home mechanical ventilation non-invasively and invasively: a 15-year cohort study in west Denmark", Amyotroph Lateral Scler Frontotemporal Degener, 15, pp.62~67 (2014)
- Mahajan KR, "Diaphragm pacing and noninvasive respiratory management of amyotrophic lateral sclerosis", motor neuron disease, 2012, pp.46, 851~855
- Onders RP, "Final analysis of the pilot trial of diaphragm pacing in amyotrophic lateral sclerosis with long-term followup:diaphragm pacing positively affects diaphragm respiration", Am J Surg, 207, pp.393~397 (2014)
- Lewis CM, "Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis", Stem Cell Res Ther, 5, pp.32~ (2014)
- Pronto-Laborinho AC, "Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis", Biomed Res Int, 2014, pp.947513~ (2014)
- Brooks BR, "El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis", Amyotroph Lateral Scler Other Motor Neuron Disord, 1, pp.293~299 (2000)
- Lee CT, "Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival:a population-based study of 1149 cases in Taiwan", J Epidemiol, 23, pp.35~40 (2013)
- Jennum P, "Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study", J Neurol, 260, pp.785~793 (2013)
- Zoccolella S, "Predictors of long survival in amyotrophic lateral sclerosis: a population-based study", J Neurol Sci, 268, pp.28~32 (2008)
- Spataro R, "Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival", J Neurol Sci, 304, pp.44~48 (2011)
- Fasano A, "Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis:a population-based registry study", Amyotroph Lateral Scler Frontotemporal Degener, 18, pp.233~242 (2017)
- del Aguila MA, "Prognosis in amyotrophic lateral sclerosis: a population-based study", Neurology, 60, pp.813~819 (2003)